Search Results - "Orrego, J"

Refine Results
  1. 1

    Two synchronous paraneoplastic endocrine syndromes in a 53-year-old male with broadly metastatic widely invasive Hürthle cell carcinoma by Orrego, John J, Chorny, Joseph A

    “…Unlike medullary thyroid carcinomas, follicular cell-derived thyroid malignancies have rarely been associated with paraneoplastic endocrine syndromes. An…”
    Get full text
    Journal Article
  2. 2

    Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer by J Orrego, John, A Chorny, Joseph

    “…Summary We describe a 56-year-old postmenopausal woman with hypertension, hypokalemia and severe alopecia who was found to have a 4.5-cm lipid-poor left…”
    Get full text
    Journal Article
  3. 3

    Thyrotoxicosis Following Fine-Needle Aspiration Biopsy of A Thyroid Nodule: Case Report by John J. Orrego

    “…Abstract Fine-needle aspiration biopsy (FNAB) is a simple and generally safe office-based procedure that accurately and cost-effectively improves the…”
    Get full text
    Journal Article
  4. 4

    AMYLOID GOITER AS THE FIRST RECOGNIZABLE MANIFESTATION OF IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS by Orrego, John J, Chorny, Joseph A

    Published in AACE clinical case reports (01-09-2019)
    “…Clinically apparent thyroid enlargement due to massive amounts of amyloid deposition, known as amyloid goiter, is rare. Endocrinologists should become familiar…”
    Get full text
    Journal Article
  5. 5

    Sporadic calcitonin-negative medullary thyroid carcinoma is not more aggressive than its classic counterpart: case report and review of the literature by John J. Orrego, Joseph A. Chorny

    “…Objective: medullary thyroid carcinoma (MTC) with normal serum basal calcitonin (calcitonin-negative MTC) is uncommon. The exact mechanism for this paradox is…”
    Get full text
    Journal Article
  6. 6

    The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas by Park, Paul, Chandler, William F, Barkan, Ariel L, Orrego, John J, Cowan, John A, Griffith, Kent A, Tsien, Christina

    Published in Neurosurgery (01-07-2004)
    “…Radiotherapy after aggressive surgical resection of nonfunctional macroadenoma (NFA) of the pituitary remains controversial. Historically, immediate…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Is Mercosur promoting trade? Insights from Argentinean wine exports by Dal Bianco, Andrea, Estrella-Orrego, Maria J., Boatto, Vasco L., Gennari, Alejandro J.

    “…As a consequence of the rapid and significative decrease in domestic demand, to avoid structural surplus traditional wine producing countries have been forced…”
    Get full text
    Journal Article
  9. 9

    Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer by Chorny, Joseph A, Orrego, John J, Cameselle-Teijeiro, José Manuel

    “…Summary Most medullary thyroid carcinomas (MTCs) are low grade and produce calcitonin. There are some calcitonin-negative MTCs that produce only calcitonin…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pituitary disorders : Drug treatment options by ORREGO, J. J, BARKAN, A. L

    Published in Drugs (New York, N.Y.) (2000)
    “…Pituitary diseases are relatively common entities in the general population. They include pituitary adenomas and hypopituitarism. Pituitary tumours can cause…”
    Get full text
    Journal Article
  12. 12

    Physiological Testosterone Replenishment in Healthy Elderly Men Does Not Normalize Pituitary Growth Hormone Output: Evidence against the Connection between Senile Hypogonadism and Somatopause by Orrego, John J., Dimaraki, Eleni, Symons, Kathy, Barkan, Ariel L.

    “…Normal aging in men is accompanied by lower serum testosterone (T), GH, and IGF-I concentrations. The mechanisms of the age-related diminution in the activity…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pergolide as primary therapy for macroprolactinomas by Orrego, J J, Chandler, W F, Barkan, A L

    Published in Pituitary (01-12-2000)
    “…The objective of this study is to determine whether pergolide therapy is an effective modality for the de novo treatment of patients with macroprolactinomas…”
    Get full text
    Journal Article
  15. 15

    Semiquantification of hypothalamic GH-releasing hormone output in women : Evidence for sexual dimorphism in the mechanism of the somatopause by ORREGO, John J, RUSSELL-AULET, Mary, DEMOTT-FRIBERG, Roberta, BARKAN, Ariel L

    “…The neuroendocrine mechanisms underlying the decline of GH with aging (somatopause) are uncertain. We recently found that the age-dependent diminution of the…”
    Get full text
    Journal Article
  16. 16

    Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine by Orrego, J J, Chandler, W F, Barkan, A L

    Published in Pituitary (01-11-2000)
    “…Prolactin (PRL)-secreting pituitary adenomas are the most common functioning pituitary tumors. Medical treatment with dopamine agonists is the therapy of…”
    Get full text
    Journal Article
  17. 17

    Bilateral symmetrical basal ganglia infarction after intravenous use of cocaine and heroin by Daras, Michael D, Orrego, John J, Akfirat, Gokhan L, Samkoff, Lawrence M, Koppel, Barbara S

    Published in Clinical imaging (2001)
    “…A case is reported of a young man who developed bilateral symmetrical basal ganglia infarcts after intravenous use of cocaine and heroin. Ischemic infarcts of…”
    Get full text
    Journal Article
  18. 18

    Efecto del programa de rehabilitación cardiaca en la calidad de vida de pacientes con enfermedad coronaria by Hernández-Vásquez, Óscar M., Jaramillo-Gómez, Carlos J., Vásquez-Trespalacios, Elsa M., Orrego-Garay, María J., Duque-González, Laura, Duque-Ramírez, Mauricio

    Published in Revista Colombiana de Cardiología (09-08-2021)
    “…Resumen Objetivo: Evaluar el efecto del programa de rehabilitación cardiaca en la calidad de vida, la clase funcional y la tolerancia al ejercicio de pacientes…”
    Get full text
    Journal Article
  19. 19
  20. 20